Skip to main content
SpringerLink
Log in

Autologous graft-versus-host disease

  • Published:
Medical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 01 June 1996

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yeager, A.M., Kaizer, H., Santos, G.W.et al. (1986) Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, usingex-vivo marrow treatment with 4-hydroperoxycyclophosphamide.N. Engl. J. Med. 315, 141–7.

    PubMed  CAS  Google Scholar 

  2. Jones, R.J., Piantadosi, S., Mann, R.B.et al. (1990) High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkins disease.J. Clin. Oncol. 8, 527–37.

    PubMed  CAS  Google Scholar 

  3. Kennedy, M.J., Beveridge, R.A., Rowley, S.D.et al. (1991) High-dose chemotherapy with reinfusion of purged autologous marrow following dose-intense induction as initial therapy for metastatic breast cancer.J. Natl. Cancer Inst. 83, 920–5.

    Article  PubMed  CAS  Google Scholar 

  4. Peters, W.P., Berry, D., Vredenburgh, J.J.et al. (1995) Five year follow up of high-dose combination alkylating agents with ABMT as consolidation after standard-dose CAF for primary breast cancer involving ≥10 axillary lymph nodes.Proc. Am. Soc. Clin. Oncol. 14, 933 (Abstract).

    Google Scholar 

  5. Passos-Coelho, J.-L., Braine, H.G., Davis, J.M.et al. (1995) Predictive factors for peripheral blood progenitor cell (PBPC) collections using a single large volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony stimulating factor (GM-CSF) mobilization.J. Clin. Oncol. 13, 705–14.

    PubMed  CAS  Google Scholar 

  6. Jones, R.J., Bedi, A., Miller, C.B.et al. (1993) Inhibition of apoptosis: A novel mechanism of resistance to multiple cytotoxic agents in acute myeloid leukemia.Exp. Hematol. 21, 1078 (Abstract).

    Google Scholar 

  7. Bedi, A., Barber, J.P., Bedi, G.C.et al. BCR-ABL-mediated inhibition of apoptosis by delay of G2/M transition following DNA damage: A mechanism of resistance to multiple anticancer agents.Blood (in press).

  8. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D. (1993) P53-dependent apoptosis modulates the cytotoxicity of anticancer agents.Cell 7, 957–67.

    Article  Google Scholar 

  9. Collins, M.K.L., Marvel, J., Malde, P. and Lopez-Rivas, A. (1992) Interleukin-3 protests murine bone marrow cells from apoptosis induced by DNA damaging agents.J. Exp. Med. 176, 1043–51.

    Article  PubMed  CAS  Google Scholar 

  10. Fuchs, E.J., Bedi, A., Jones, R.J. and Hess, A.D. (1995) Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.Cancer Res. 55, 463–6.

    PubMed  CAS  Google Scholar 

  11. Vaux, D.L., Aguila, H.L. and Weissman, I.L. (1992) Bcl-2 prevents death of factor deprived cells but fails to prevent apoptosis in targets of cell mediated killing.Int. Immunol. 4, 821–4.

    Article  PubMed  CAS  Google Scholar 

  12. Kersey, J.H., Weisdorf, D., Nesbit, M.E.et al. (1987) Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.N. Engl. J. Med. 317, 461–7.

    PubMed  CAS  Google Scholar 

  13. Weiden, P.L., Fluornoy, N., Thomas, E.D.et al. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.N. Engl. J. Med. 300, 1068–73.

    PubMed  CAS  Google Scholar 

  14. Weiden, P.L., Sullivan, K.M., Fluornoy, N., Storb, R. and Thomas, E.D. (1981) Antileukemic effect of graft versus host disease. Contribution to improved survival after allogeneic marrow transplantation.N. Engl. J. Med. 304, 1529–33.

    PubMed  CAS  Google Scholar 

  15. Butturini, A., Bortin, M.M. and Gale, R.P. (1987) Graft-versus-leukemia following bone marrow transplantation.Bone Marrow Transpl. 2, 233–42.

    CAS  Google Scholar 

  16. Horowitz, M.M., Gale, R.P., Sondel, P.M.et al. (1990) Graft-versus-leukemia reactions after bone marrow transplantation.Blood 75, 555–62.

    PubMed  CAS  Google Scholar 

  17. Jones, R.J., Ambinder, R.F., Piantadosi, S. and Santos, G.W. (1991) Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.Blood 77, 649–53.

    PubMed  CAS  Google Scholar 

  18. Santos, G.W. (1970) Effect of graft-versus-host-disease on a spontaneous adenocarcinoma in mice.Exp. Hematol. 20, 46–8.

    Google Scholar 

  19. Fefer, A. (1970) Immunotherapy of primary Moloney sarcoma virus-induced tumors.Int. J. Cancer 5, 327–32.

    Article  PubMed  CAS  Google Scholar 

  20. Foon, K.A. and Todd, R.F. III. (1986) Immunologic classification of leukemia and lymphoma.Blood 68, 1–31.

    PubMed  CAS  Google Scholar 

  21. Zuk, J.A. and Walker, R.A. (1988) HLA class II sublocus expression in benign and malignant breast epithelium.J. Pathol. 155, 301–9.

    Article  PubMed  CAS  Google Scholar 

  22. Gastl, G., Marth, C., Leiter, E.et al. Effects of human recombinantα 2 arg-interferon andγ-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.Cancer Res. 45, 2957-61.

  23. Glazier, A., Tutschka, P.J., Farmer, E.R. and Santos, G.W. (1983) Graft-versus-host disease in cyclosporine A treated rats after syngeneic and autologous bone marrow transplantation.J. Exp. Med. 158, 1–8.

    Article  PubMed  CAS  Google Scholar 

  24. Glazier, A. Tutschka, P.J. and Farmer, E.R. (1983) Studies on the immunobiology of syngeneic and autologous graft-versus-host disease in cyclosporine treated rats.Transplant. Proc. 15, 3035.

    Google Scholar 

  25. Beschorner, W.E., Shinn, C.A., Fischer, A.C., Santos, G.W. and Hess, A.D. (1988) Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period.Transplantation 46, 112–7.

    Article  Google Scholar 

  26. Hess, A.D., Horwitz, L., Beschorner, W.E. and Santos, G.W. (1985) Development of graft-versus-host disease like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation.J. Exp. Med. 161, 718–30.

    Article  PubMed  CAS  Google Scholar 

  27. Sorokin, R., Kimura, H., Schroder, K. and Wilson, D.B. (1986) Cyclosporine-induced autoimmunity: Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.J. Exp. Med. 164, 1615–25.

    Article  PubMed  CAS  Google Scholar 

  28. Jenkins, M.K., Schwartz, R.H. and Pardoll, D.M. (1988) Effects of cyclosporine A on T cell development and clonal deletion.Science 241, 1655–8.

    Article  PubMed  CAS  Google Scholar 

  29. Hess, A.D. and Fischer, A.C. (1989) Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.Transplantation 48, 895–900.

    Article  PubMed  CAS  Google Scholar 

  30. Hess, A.D., Fischer, A.C. and Beschorner, W.E. (1990) Effector mechanisms in cyclosporine A induced syngeneic graft-versus-host disease: Role of CD4+ and CD8+ T lymphocyte subsets.J. Immunol. 145, 526–33.

    PubMed  CAS  Google Scholar 

  31. Morris, L.M., Vogelsang, G.B., Bright, E.C., Jones, R.J., Santos, G.W. and Hess, A.D. (1993) Immune Reconstitution in cyclosporine-induced autologous GVHD.Blood 80, 136 (Abstract).

    Google Scholar 

  32. Geller, G.B., Esa, A.H., Beschorner, W.E., Frondoza, C.G., Santos, G.W. and Hess, A.D. (1989) Successfulin vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.Blood 74, 1165–71.

    PubMed  CAS  Google Scholar 

  33. Fischer, A.C., Ruvolo, P.P., Burt, R.et al. (1995) Characterization of the autoreactive T cell repertoire in cyclosporine-induced syngeneic graft-versus-host disease.J. Immunol. 154, 3713–25.

    PubMed  CAS  Google Scholar 

  34. Fischer, A.C., Ruvolo, P.P., Horwitz, L.R. and Hess, A.D. (1995) Analysis of Vβ T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.Transplant. Proc. 27, 1366–9.

    PubMed  CAS  Google Scholar 

  35. Hess, A.D., Jones, R., Vogelsang, G.B. and Santos, G.W. (1991) Syngeneic graft-versus-host disease: Fundamental mechanisms and clinical applications. In R. Gale and R. Champlin (eds)New Strategies in Bone Marrow Transplantation, pp. 61–72. New York, Wiley.

    Google Scholar 

  36. Jones, R.J., Vogelsang, G.B., Hess, A.D.et al. (1989) Induction of graft-versus-host disease after autologous bone marrow transplantation.Lancet 1, 754–57.

    Article  PubMed  CAS  Google Scholar 

  37. Jones, R.J., Vogelsang, G.B., Ambinder, R.F., Santos, G.W. and Hess, A.D. (1991) Autologous marrow transplantation (ABMT) with cyclosporine (CSA)-induced autologous graft-versus-host disease (GVHD) for relapsed aggressive non-Hodgkins lymphoma (NHL).Blood 78, 287 (Abstract).

    Google Scholar 

  38. Philip, T., Armitage, J.O., Spitzer, G.et al. (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkins lymphoma.N. Engl. J. Med. 316, 1493–8.

    PubMed  CAS  Google Scholar 

  39. Yeager, A.M., Vogelsang, G.B., Jones, R.L.et al. (1992) Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.Blood 79, 3031–5.

    PubMed  CAS  Google Scholar 

  40. Bernard, D., Maurizis, J.-C., Ruse, F., Chassagne, J., Chollet, P., Sauvezie, B., De Latour, M. and Plagne, R. (1984) Presence of HLA-D/DR antigens on the membrane of breast tumor cells.Clin. Exp. Immunol. 56, 215–21.

    PubMed  CAS  Google Scholar 

  41. Natali, P.G., Giacomini, P., Bigotti, A.et al. (1983) Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.Cancer Res. 43, 660–8.

    PubMed  CAS  Google Scholar 

  42. Whitwell, H.L., Hughes, H.P.A., Moore, M. and Ahmed, A. (1984) Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.Br. J. Cancer 49, 161–172.

    PubMed  CAS  Google Scholar 

  43. Kennedy, M.J., Vogelsang, G.B., Beveridge, R.A.et al. (1993) Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.J. Clin. Oncol. 11, 478–4.

    PubMed  CAS  Google Scholar 

  44. Schwartz, R., Momburg, F., Moldenhauer, G., Dorken, B. and Schirrmacher, V. (1985) Induction of HLA Class-II antigen expression on human carcinoma cell lines by IFN-gamma.Int. J. Cancer 35, 245–50.

    Article  PubMed  CAS  Google Scholar 

  45. Dolei, A., Capobianchi, M.R. and Ameglio, F. (1983) Humanγ-interferon enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively thanα-interferon andβ-interferon.Infect. Immunol. 40, 172–6.

    CAS  Google Scholar 

  46. Kennedy, M.J., Vogelsang, G.B., Jones, R.J.et al. (1994) Phase I trial of interferon-gamma to potentiate cyclosporine A-induced graft-versus-host-disease in women under-going autologous bone marrow transplantation for breast cancer.J. Clin. Oncol. 12, 249–57.

    PubMed  Google Scholar 

  47. Ruvolo, P., Bright, E., Kennedy, M.J.et al. (1995) Cyclosporine-induced autologous graft versus host disease: Assessment of cytolytic effector mechanisms and the Vβ T-cell receptor repertoire.Transplant. Proc. 27, 1363–5.

    PubMed  CAS  Google Scholar 

  48. Kennedy, M.J., Hess, A.D., Passos-Coehlo, J.-L.et al. (1995) Peripheral blood progenitor cell infusions do not inhibit the induction of autologous graft-vs-host disease by cyclosporine a following high-dose chemotherapy.Proc. Am. Soc. Clin. Oncol. 14, 915 (Abstract).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Johns Hopkins Oncology Center, 21287, Baltimore, MD, USA

    M. John Kennedy & Allan D. Hess

Authors
  1. M. John Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allan D. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

To whom correspondence should be addressed

An erratum to this article is available at http://dx.doi.org/10.1007/BF02993864.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kennedy, M.J., Hess, A.D. Autologous graft-versus-host disease. Med Oncol 12, 149–156 (1995). https://doi.org/10.1007/BF01571192

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01571192

Keywords

Search

Navigation